Actavis v Eli Lilly: a commentary

22 December 2014

Paul England

Simmons & Simmons
Consulting Editor of Intellectual Property in the Life Sciences

Paul England, a specialist in life science patent litigation at Taylor Wessing, provides commentary on the landmark win for Actavis paving the way for cross-border declarations of patent non-infringement.

Paul England, a specialist in life science patent litigation at Taylor Wessing, provides commentary on the landmark win for Actavis, paving the way for cross-border declarations of patent non-infringement.